EP2925274B1 - Connector for fluid communication - Google Patents
Connector for fluid communication Download PDFInfo
- Publication number
- EP2925274B1 EP2925274B1 EP13798332.6A EP13798332A EP2925274B1 EP 2925274 B1 EP2925274 B1 EP 2925274B1 EP 13798332 A EP13798332 A EP 13798332A EP 2925274 B1 EP2925274 B1 EP 2925274B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- outer sleeve
- tubular body
- fluid connector
- connector
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 title claims description 98
- 238000004891 communication Methods 0.000 title claims description 13
- 230000000717 retained effect Effects 0.000 claims description 9
- 239000003086 colorant Substances 0.000 claims description 7
- 230000007704 transition Effects 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/1782—Devices aiding filling of syringes in situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
Definitions
- the present invention relates to a connector for enabling fluid transfer between a first fluid container, such as a syringe, and a second fluid container or vial adapter.
- Fluid connectors, fluid transfer devices, vial adapters, and similar medical apparatuses are commonly used for establishing fluid communication between two medical containers for the purpose of drug reconstitution. Specifically, these devices assist a user to introduce a diluent contained within a first container to a solid, powdered, or lyophilized drug component, contained in a second medical container, such as a medical vial.
- Fluid connectors are often used to create a secure connection between a syringe and a second medical container.
- the fluid connector serves as an adapter for establishing a connection between the syringe nozzle and the second medical container or an adapter secured to the second medical container.
- a commonly available fluid connector includes structure for establishing fluid communication between the first container and the second container. Often the fluid flow path through the connector is defined by a needle cannula extending from a first access port, through the connector, to a second access port.
- the connector may be transitioned from a first position in which the ports are in fluid isolation to a second position in which fluid communication between the ports is established.
- the connector device includes a telescoping tubular body which can be pressed together to bring the access ports closer together and into contact with the respective ends of the needle.
- a user attaches the medical containers to the ends of the device and then presses on the device body to move the access ports towards one another.
- the tip of the needle may pierce the ports or medical container closures. In this way, the fluid within the containers is accessible and can be transferred from one container to the other.
- one or both of the access ports includes structure adapted for connection to a corresponding structure of a medical container.
- the fluid connector Once the fluid connector has been engaged with the container, there is a risk that the connector may be accidentally or inadvertently disconnected, which could cause fluid contained within the container to leak through the access port, possibly coming into contact with the user.
- Accidental disconnection of the container and connector presents a serious contamination risk for patients and medical practitioners. Avoiding contamination is especially important when the fluid connector is used to prepare and/or administer a toxic fluid, such as cytostatic agents.
- Some medical connectors are further configured to prevent the user from accidentally disconnecting the connector from the container after fluid transfer has been performed.
- these connectors generally do not provide feedback to users about when or if a safe connection has been established between the medical containers. Such connectors also often still allow a user to inadvertently disconnect the connector from the medical container.
- existing connectors often have a complex external structure which may be confusing for users and may cause users to inadvertently grasp the wrong portion of the connector and to inadvertently disconnect the connector. Examples of conventional medical connectors are shown in U.S. Patent Nos. 7,306,584 ; 7,867,215 ; 7,975,733 ; and 8,225,826 .
- Document WO2008/136720 A1 describes a fluid connector comprising an adapter removably attachable to a first container, an outer sleeve connected to the adapter and a tubular body retained partially within the outer sleeve and having a distal end connected to a second container.
- a fluid connector includes an adapter configured to removably attach to a first container with the adapter having an access port and a cap.
- An outer sleeve is connected to the adapter and a tubular body is retained at least partially within the outer sleeve.
- the body has a proximal end connected to the adapter and a distal end connected to a second container where the fluid connector is transitionable from a first position in which the first container and the second container are in fluid isolation, to a second position in which the first container and the second container are in fluid communication.
- At least a portion of the cap of the adapter is retained within the outer sleeve.
- At least a portion of the cap of the adapter is retained within the outer sleeve.
- the outer sleeve further comprises an enlarged end portion configured to cover the distal end of the tubular body, when the connector is in the second position. In the first position, the tubular body extends beyond a distal end of the outer sleeve and in the second position the outer sleeve covers the distal end of the tubular body.
- a portion of the cap retained within the outer sleeve may include a latching mechanism configured to engage a corresponding latching structure positioned on an inner sidewall of the outer sleeve.
- the tubular body may include a needle extending longitudinally through the tubular body from the proximal end to the distal end with the needle defining a lumen. In the first position, the needle may be entirely enclosed within the fluid connector, and in the second position, the needle may extend beyond a distal end of the fluid connector.
- the outer sleeve may include a latch for establishing a non-removable engagement with the distal end of the tubular body.
- the outer sleeve may include a grip portion.
- the outer sleeve may have a first dominant color and the tubular body may have a second color, with the second color being non-dominant.
- the tubular body may include a detent, and the outer sleeve may include a notch which, when the connector is in the second position, accepts the detent.
- the detent may be visible to a user after it is accepted within the notch of the outer sleeve.
- the outer sleeve may be a first dominant color, the detent may be a second dominant color, and the tubular body may be a non-dominant color.
- the outer sleeve may include visible lines which are configured to direct a user's attention to the notch.
- a fluid connector 10 including a tubular body 12 , an outer sleeve 14 , and an adapter 16.
- the fluid connector 10 is configured to establish fluid communication between a first medical container 18 and a second medical container 19 or between a medical container 18 and a further apparatus, such as a vial adapter 20 .
- Commonly used medical fluid containers include syringes, vials, cartridges, fluid containing bags, medical lines, or similar structures and conduits for holding medical fluids such as drugs, solvents, and diluents.
- the fluid connector 10 connected between a medical container 18 (e.g., a syringe) and a vial adapter 20 is depicted in FIG.
- the fluid connector 10 is used to establish fluid communication between the containers so that a user may inject fluid from one container 18 to the other or may draw fluid from one container to the other.
- the fluid connector 10 also includes structure for locking the device to the first and/or second medical containers and to maintain the connection between the connector and container. Fluid communication between the medical containers is established by moving the outer sleeve 14 from a first position in which a portion of the tubular body 12 extends from the outer sleeve 14 , to a second, engaged position in which the outer sleeve 14 encloses the tubular body 12 .
- the fluid connector 10 is shown in the first position in FIG. 4 , and in the second position in FIG. 5 . The components of the fluid connector 10 are discussed in greater detail below.
- the tubular body 12 has a proximal end 30 located near the adapter 16 and includes an inner sleeve 15 that is received within the tubular body 12 .
- the inner sleeve 15 includes a distal end 32 terminating in a pierceable septum 34 or membrane.
- the tubular body 12 further includes a needle 36 (shown in FIGS. 11 and 12 ) extending longitudinally through the inner sleeve 15 and tubular body 12 from the proximal end 30 to the distal end 32 .
- the needle 36 defines a lumen which provides a fluid path through the tubular body 12 and inner sleeve 15 .
- the needle 36 is formed from medical grade metal or other material capable of being sharpened to a tip 38 , capable of piercing the septum 34 .
- the needle 36 has a first position in which it is entirely enclosed within the tubular body 12 and a second, exposed position where the needle 36 is forced through the septum 34 and brought into contact with the second medical container 19 or vial adapter 20 .
- the tubular body 12 and inner sleeve 15 are formed from hard plastic or other lightweight but substantially rigid material, although other suitable materials may be utilized.
- the tubular body 12 and inner sleeve 15 should be sufficiently strong and rigid so that it will not flex or deform during use, specifically when a user pushes on the fluid connector 10 to attach the connector to the medical container 18 or vial adapter 20 .
- the distal end 32 of the inner sleeve 15 includes a locking structure 40 such as projections, detents, ribs, or threaded connections for connecting the connector 10 to a medical container 19 or vial adapter 20 .
- the distal end 32 of the inner sleeve 15 comprises a male connector 42 configured to be received within a female connector of the container 19 or adapter 20 .
- a user would insert the male connector 42 into the corresponding female connector and twist the tubular body 12 via the outer sleeve 14 to lock it in place.
- the twisting motion may also be used to release the needle 36 so that it may be moved distally through the tubular body 12 .
- the inner sleeve 15 includes structure that cooperates with corresponding structure of the tubular body 12 to selectively allow the inner sleeve 15 to rotate relative to the tubular body 12 which, in turn, allows the needle 36 to be advanced through the septum 34 .
- rotation of the outer sleeve 14 causes rotation of the inner sleeve 15 to secure the locking structure 40 to the container 19 or adaptor 20 and also allow the needle to extend through the septum 34 .
- the outer sleeve 14 of the fluid connector 10 is connected to the adapter 16 and at least partially encloses the tubular body 12 .
- the outer sleeve 14 is configured to be grasped by a user when inserting the connector to the medical container 18 or vial adapter 20 .
- the outer sleeve 14 may have an ergonomic grip 50 to facilitate holding by a user and to improve user comfort.
- the outer sleeve 14 is configured to slide longitudinally along the tubular body 12 as the connector 10 transitions from the first position to the second position.
- the connector 10 is transitioned between the first position and the second position by pushing or moving the outer sleeve 14 in a longitudinal direction toward the distal end 32 , thereby advancing the outer sleeve 14 in the distal direction.
- the transition of the outer sleeve 14 brings a portion of the adapter 16 in contact with the proximal end 30 of the tubular body 12 and advances the needle 36 through the tubular body 12 , as described above, to establish fluid communication between the medical containers 18, 19 .
- the outer sleeve 14 may include one or more longitudinal grooves 52 extending along the inner surface of the sleeve 14 .
- the longitudinal grooves 52 are adapted to receive a longitudinal ridge 44 , as shown in FIG. 1 , extending along the tubular body 12 . Insertion of the ridge 44 within the groove 52 prevents the outer sleeve 14 from rotating relative to the tubular body 12 as the sleeve 14 is pressed downward along the body 12 .
- the outer sleeve 14 may include an enlarged extension 54 , as shown in FIGS. 8-9 , at the distal end of the sleeve 14 .
- the extension 54 is adapted to cover the tubular body 12 and the distal end 32 of the inner sleeve 15 including the portion of the inner sleeve 15 which engages the container 18 or vial adapter 20 .
- the outer sleeve 14 is configured with a locking mechanism for further securing the outer sleeve 14 in the second position.
- the outer sleeve 14 may include inward projections 56 located near the distal end of the sleeve 14 .
- the projections 56 may also be positioned on the inner surface of the enlarged extension 54 of the sleeve 14 .
- the projections 56 are configured to grasp and maintain contact with corresponding latches 46 extending radially from the distal end 32 of the tubular body 12 .
- the projections 56 engage the latches 46 of the tubular body 12 forming a secure connection therewith.
- the engagement between the projections 56 and latches 46 maintains the sleeve 14 and tubular member 12 in the second position, thereby reducing the chance of inadvertent disconnection.
- the adapter 16 includes a threaded port 70 , a cap 72 , and a hollow rod 74 .
- the outer sleeve 14 is connected to the adapter 16 at a proximal portion of the sleeve 14 .
- the outer sleeve 14 may include a proximal locking structure 58 , as shown in FIG. 10 , such as an inwardly projecting rib, latch, or teeth extending from an inner surface of the sleeve 14 to contact and engage the adapter 16 .
- the engagement between the adapter 16 and outer sleeve 14 may prevent rotation of the adapter 16 with respect to the sleeve 14 .
- the threaded port 70 is configured to connect with a nozzle of a syringe thereby establishing the fluid connection between the medical container 18 and the fluid connector 10 .
- the threaded port 70 extends proximally outward from the cap 72 .
- the cap 72 is generally cylindrical and configured to be inserted in the open proximal end of the outer sleeve 14 .
- the cap 72 may include a protrusion 76 , which corresponds to the proximal lock 58 of the outer sleeve 14 , for retaining the cap within the outer sleeve.
- the engagement between the cap 72 and outer sleeve 14 may also prevent rotation of the adapter 16 relative to the outer sleeve 14 .
- the rod 74 extends distally from the threaded port 70 toward the tubular body 12 .
- the rod 74 is rigidly attached to the needle 36 and includes a fluid channel extending through the rod 74 for fluid transfer from the threaded port 70 to the needle 36 .
- the rod 74 is directed distally and is received within the tubular body 12 .
- Continued distal movement of the rod 74 advances a portion of the needle 36 through the tubular body 12 , thereby exposing the tip 38 of the needle 36 through the distal end 32 of the tubular body 12 .
- the cap 72 rests against the proximal end 30 of the tubular body 12 , and the rod 74 is entirely enclosed within the tubular body 12 .
- the fluid connector 10 is configured to have a minimized diameter.
- the cap 72 is contained almost entirely within the outer sleeve 14 such that only a proximal most portion of the cap 72 and the threaded port 70 extend beyond the end of the sleeve 14 .
- the cap 72 and at least a portion of the sleeve 14 have substantially the same diameter.
- An outer sleeve 14 with a reduced diameter can be handled more easily by users.
- a slimmer outer sleeve 14 is generally more visually pleasing and reduces the apparent complexity of the connector 10 by limiting the components which are visible to a user.
- the cap 72 is configured to cover the sleeve 14 such that a portion of the sleeve 14 is enclosed within an interior cavity formed by the cap 72 .
- connection between the adapter 16 and outer sleeve 14 is a selective rotational engagement which can be transitioned from a freely rotatable configuration in which the adapter 16 can be rotated 360 degrees to a locked or non-rotatable position where rotation of the adapter 16 is prevented.
- the protrusion 76 of the cap 72 forms a ratcheting engagement with the proximal lock 58 of the outer sleeve 14 to allow a syringe or medical container 18 to be connected to the threaded port 70 , but discouraging accidental disconnection.
- the adapter 16 will rotate relative to the outer sleeve 14 to discourage disconnection.
- the connector 10 is provided with a part having a dominant color 80 , shown in cross-hatch, and a part having a non-dominant color 82 .
- a part having a dominant color 80 shown in cross-hatch
- a part having a non-dominant color 82 Users are more likely to grasp and attempt to manipulate portions of a device with the dominant color 80 . Therefore, the outer sleeve 14 , and specifically the gripping portion 50 of the outer sleeve 14 , is provided in the dominant color 80 .
- Dominant colors include red, blue, neon colors, or black, although other suitable dominant colors may be utilized.
- the tubular body 12 which is not intended to be grasped by the user, is provided in a non-dominant color 82 .
- Non-dominant colors include pastels, neutral colors such as tan, and white. Since the outer sleeve 14 slides distally along the tubular body 12 it is preferable that the user does not attempt to grasp the tubular body 12 . Grasping the body 12 would prevent the distal movement of the outer sleeve 14 . Using a dominant and non-dominant color scheme encourages the user to hold the correct portion of the fluid connector 10 .
- the tubular body 12 may further include a visible detent 84 , such as a semispherical projection, extending radially from the outer surface of the tubular body 12 .
- the visible detent 84 should be a dominant, highly visible color 86 .
- the visible detent 84 corresponds to and is adapted to be received within a circular notch 88 in the outer sleeve 14 .
- the detent 84 is configured to be received within the notch 88 when the sleeve 14 is in the second position.
- the outer sleeve 14 may include visible markings 90 which draw the user's attention to the notch 88 . These markings serve to direct the user's attention to the visible detent 84 and encourage the user to check whether the detent 84 and notch 88 are aligned before beginning to inject fluid through the fluid connector 10 .
- the detent 84 may also provide a tactile or haptic feedback to indicate when the connector 10 is in the proper position when in use.
- Including features such as the dominant 80 and non-dominant 82 color scheme and visible detent 84 increases user confidence when using the connector 10 .
- the structure and appearance of the device is designed to encourage the user to use the device correctly and to provide visual, tactile, or haptic feedback when a use step has been correctly completed.
- the visual, tactile, or haptic feedback inspires confidence in a user that subsequent steps will also be correctly completed.
- the fluid connector 10 is initially provided in the first position, as shown, for example, in FIGS. 1 and 2A .
- the user attaches a syringe to the adapter 16 at the threaded port 70 .
- the user places the syringe nozzle about the threaded port 70 and rotates the syringe, thereby engaging the threads of the port 70 with corresponding threads on the inner surface of the syringe nozzle.
- the device is prepared to be transitioned from the first position to the second position, by distally advancing the outer sleeve 14 relative to the tubular body 12 .
- the user continues to push the outer sleeve 14 in the distal direction until the tubular body 12 is entirely enclosed by the outer sleeve 14 and the outer sleeve cannot advance any further in the distal direction.
- the user is provided with a visual indication that the connector 10 is in the proper position by the detent 84 being received within the notch 88 .
- the detent 84 and notch 88 are effectively aligned, the user is assured that the device is in the second position, and that fluid communication between the first and second medical containers 18, 19 through the needle 36 has been established.
- fluid communication between the first and second containers 18, 19 is established the user is ready to inject fluid from one container 18 to the other 19 or to draw fluid between containers 18, 19 .
- the second container 19 affixed to the distal end of the connecter 10 can be removed by moving the sleeve 14 relative to the body 12 to return the connector 10 back to the first position and then grasping and rotating the sleeve 14 and locking structure 40 to disengage the locking structure 40 from the vial adaptor 20 .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Feeding And Controlling Fuel (AREA)
Description
- The present invention relates to a connector for enabling fluid transfer between a first fluid container, such as a syringe, and a second fluid container or vial adapter.
- Fluid connectors, fluid transfer devices, vial adapters, and similar medical apparatuses are commonly used for establishing fluid communication between two medical containers for the purpose of drug reconstitution. Specifically, these devices assist a user to introduce a diluent contained within a first container to a solid, powdered, or lyophilized drug component, contained in a second medical container, such as a medical vial.
- Fluid connectors are often used to create a secure connection between a syringe and a second medical container. In this way, the fluid connector serves as an adapter for establishing a connection between the syringe nozzle and the second medical container or an adapter secured to the second medical container. A commonly available fluid connector includes structure for establishing fluid communication between the first container and the second container. Often the fluid flow path through the connector is defined by a needle cannula extending from a first access port, through the connector, to a second access port.
- In some configurations, the connector may be transitioned from a first position in which the ports are in fluid isolation to a second position in which fluid communication between the ports is established. For example, in some known fluid connector devices, the connector device includes a telescoping tubular body which can be pressed together to bring the access ports closer together and into contact with the respective ends of the needle. In these devices, a user attaches the medical containers to the ends of the device and then presses on the device body to move the access ports towards one another. As the access ports are brought closer together, the tip of the needle may pierce the ports or medical container closures. In this way, the fluid within the containers is accessible and can be transferred from one container to the other.
- In some fluid connector apparatuses, one or both of the access ports includes structure adapted for connection to a corresponding structure of a medical container. However, once the fluid connector has been engaged with the container, there is a risk that the connector may be accidentally or inadvertently disconnected, which could cause fluid contained within the container to leak through the access port, possibly coming into contact with the user. Accidental disconnection of the container and connector presents a serious contamination risk for patients and medical practitioners. Avoiding contamination is especially important when the fluid connector is used to prepare and/or administer a toxic fluid, such as cytostatic agents.
- Some medical connectors are further configured to prevent the user from accidentally disconnecting the connector from the container after fluid transfer has been performed. However, these connectors generally do not provide feedback to users about when or if a safe connection has been established between the medical containers. Such connectors also often still allow a user to inadvertently disconnect the connector from the medical container. Furthermore, existing connectors often have a complex external structure which may be confusing for users and may cause users to inadvertently grasp the wrong portion of the connector and to inadvertently disconnect the connector. Examples of conventional medical connectors are shown in
U.S. Patent Nos. 7,306,584 ;7,867,215 ;7,975,733 ; and8,225,826 . - Document
WO2008/136720 A1 describes a fluid connector comprising an adapter removably attachable to a first container, an outer sleeve connected to the adapter and a tubular body retained partially within the outer sleeve and having a distal end connected to a second container. - A fluid connector includes an adapter configured to removably attach to a first container with the adapter having an access port and a cap. An outer sleeve is connected to the adapter and a tubular body is retained at least partially within the outer sleeve. The body has a proximal end connected to the adapter and a distal end connected to a second container where the fluid connector is transitionable from a first position in which the first container and the second container are in fluid isolation, to a second position in which the first container and the second container are in fluid communication. At least a portion of the cap of the adapter is retained within the outer sleeve. At least a portion of the cap of the adapter is retained within the outer sleeve. The outer sleeve further comprises an enlarged end portion configured to cover the distal end of the tubular body, when the connector is in the second position. In the first position, the tubular body extends beyond a distal end of the outer sleeve and in the second position the outer sleeve covers the distal end of the tubular body.
- A portion of the cap retained within the outer sleeve may include a latching mechanism configured to engage a corresponding latching structure positioned on an inner sidewall of the outer sleeve. The tubular body may include a needle extending longitudinally through the tubular body from the proximal end to the distal end with the needle defining a lumen. In the first position, the needle may be entirely enclosed within the fluid connector, and in the second position, the needle may extend beyond a distal end of the fluid connector. The outer sleeve may include a latch for establishing a non-removable engagement with the distal end of the tubular body. The outer sleeve may include a grip portion. The outer sleeve may have a first dominant color and the tubular body may have a second color, with the second color being non-dominant. The tubular body may include a detent, and the outer sleeve may include a notch which, when the connector is in the second position, accepts the detent. The detent may be visible to a user after it is accepted within the notch of the outer sleeve. The outer sleeve may be a first dominant color, the detent may be a second dominant color, and the tubular body may be a non-dominant color. The outer sleeve may include visible lines which are configured to direct a user's attention to the notch.
- The following description is provided to enable those skilled in the art to make and use the described embodiments contemplated for carrying out the invention. Various modifications, equivalents, variations, and alternatives, however, will remain readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to fall within the scope of the present invention.
-
FIG. 1 is a perspective view of a fluid connector configured in the first or storage position in accordance with an embodiment of the present invention. -
FIG. 2A is a front view of the fluid connector ofFIG. 1 in accordance with an embodiment of the present invention. -
FIG. 2B is a cross-sectional view of the fluid connector ofFIG. 1 taken along theline 2B-2B inFIG. 2A . -
FIG. 3 is a perspective view of the fluid connector ofFIG. 1 connected to a syringe on one end and to a vial adapter on the other, in accordance with an embodiment of the present invention. -
FIG. 4 is a front view of the fluid connector ofFIG. 1 connected to a vial adapter, in the first position in accordance with an embodiment of the present invention. -
FIG. 5 is a front view of the fluid connector ofFIG. 1 in the second position in accordance with an embodiment of the present invention. -
FIG. 6 is a perspective view of the fluid connector ofFIG. 1 with the outer sleeve removed to reveal the adapter and tubular body in accordance with an embodiment of the present invention. -
FIG. 7 is a front view of the fluid connector ofFIG. 1 with the outer sleeve removed in accordance with an embodiment of the present invention. -
FIG. 8 is a perspective view of the outer sleeve of the fluid connector ofFIG. 1 in accordance with an embodiment of the present invention. -
FIG. 9 is a front view of the outer sleeve ofFIG. 8 in accordance with an embodiment of the present invention. -
FIG. 10 is a top view of the outer sleeve ofFIG. 8 in accordance with an embodiment of the present invention. -
FIG. 11 is a partial cross-sectional view of the fluid connector ofFIG. 1 , showing the connection between the distal end of the connector and the vial adapter in accordance with an embodiment of the present invention. -
FIG. 12 is a front view of the fluid connector ofFIG. 1 with the outer sleeve and tubular body removed to further show the adapter and needle in accordance with an embodiment of the present invention. -
FIG. 13 is a front view of the fluid connector ofFIG. 1 showing various indication arrangements in accordance with an embodiment of the present invention. - For the purpose of facilitating understanding of the invention, the accompanying drawings and description illustrate preferred embodiments thereof, from which the invention, various embodiments of its structures, construction and method of operation, and many advantages may be understood and appreciated.
- For purposes of the description hereinafter, the terms "upper", "lower", "right", "left", "vertical", "horizontal", "top", "bottom", "lateral", "longitudinal", and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.
- With reference to
FIGS. 1-5 , afluid connector 10 is shown including atubular body 12, anouter sleeve 14, and anadapter 16. Thefluid connector 10 is configured to establish fluid communication between a firstmedical container 18 and a secondmedical container 19 or between amedical container 18 and a further apparatus, such as avial adapter 20. Commonly used medical fluid containers, as is known in the art, include syringes, vials, cartridges, fluid containing bags, medical lines, or similar structures and conduits for holding medical fluids such as drugs, solvents, and diluents. Thefluid connector 10 connected between a medical container 18 (e.g., a syringe) and avial adapter 20 is depicted inFIG. 4 . Thefluid connector 10 is used to establish fluid communication between the containers so that a user may inject fluid from onecontainer 18 to the other or may draw fluid from one container to the other. Thefluid connector 10 also includes structure for locking the device to the first and/or second medical containers and to maintain the connection between the connector and container. Fluid communication between the medical containers is established by moving theouter sleeve 14 from a first position in which a portion of thetubular body 12 extends from theouter sleeve 14, to a second, engaged position in which theouter sleeve 14 encloses thetubular body 12. Thefluid connector 10 is shown in the first position inFIG. 4 , and in the second position inFIG. 5 . The components of thefluid connector 10 are discussed in greater detail below. - With reference to
FIGS. 6 and7 , thetubular body 12 has aproximal end 30 located near theadapter 16 and includes aninner sleeve 15 that is received within thetubular body 12. Theinner sleeve 15 includes adistal end 32 terminating in apierceable septum 34 or membrane. Thetubular body 12 further includes a needle 36 (shown inFIGS. 11 and12 ) extending longitudinally through theinner sleeve 15 andtubular body 12 from theproximal end 30 to thedistal end 32. Theneedle 36 defines a lumen which provides a fluid path through thetubular body 12 andinner sleeve 15. Theneedle 36 is formed from medical grade metal or other material capable of being sharpened to atip 38, capable of piercing theseptum 34. Theneedle 36 has a first position in which it is entirely enclosed within thetubular body 12 and a second, exposed position where theneedle 36 is forced through theseptum 34 and brought into contact with the secondmedical container 19 orvial adapter 20. Thetubular body 12 andinner sleeve 15 are formed from hard plastic or other lightweight but substantially rigid material, although other suitable materials may be utilized. Thetubular body 12 andinner sleeve 15 should be sufficiently strong and rigid so that it will not flex or deform during use, specifically when a user pushes on thefluid connector 10 to attach the connector to themedical container 18 orvial adapter 20. - The
distal end 32 of theinner sleeve 15 includes a lockingstructure 40 such as projections, detents, ribs, or threaded connections for connecting theconnector 10 to amedical container 19 orvial adapter 20. In certain embodiments, thedistal end 32 of theinner sleeve 15 comprises amale connector 42 configured to be received within a female connector of thecontainer 19 oradapter 20. In that case, a user would insert themale connector 42 into the corresponding female connector and twist thetubular body 12 via theouter sleeve 14 to lock it in place. The twisting motion may also be used to release theneedle 36 so that it may be moved distally through thetubular body 12. In that way, thetip 38 of theneedle 36 is safely retained within thetubular body 12 until thedistal end 32 of thetubular body 12 is connected in the female connector. More specifically, theinner sleeve 15 includes structure that cooperates with corresponding structure of thetubular body 12 to selectively allow theinner sleeve 15 to rotate relative to thetubular body 12 which, in turn, allows theneedle 36 to be advanced through theseptum 34. Thus, rotation of theouter sleeve 14 causes rotation of theinner sleeve 15 to secure the lockingstructure 40 to thecontainer 19 oradaptor 20 and also allow the needle to extend through theseptum 34. - With reference to
FIGS. 8-10 , theouter sleeve 14 of thefluid connector 10 is connected to theadapter 16 and at least partially encloses thetubular body 12. Theouter sleeve 14 is configured to be grasped by a user when inserting the connector to themedical container 18 orvial adapter 20. As such, theouter sleeve 14 may have anergonomic grip 50 to facilitate holding by a user and to improve user comfort. - As shown in
FIGS. 4 and5 , theouter sleeve 14 is configured to slide longitudinally along thetubular body 12 as theconnector 10 transitions from the first position to the second position. After securing theconnector 10 to theadapter 20 by twisting or rotating thesleeve 14 and lockingstructure 40, theconnector 10 is transitioned between the first position and the second position by pushing or moving theouter sleeve 14 in a longitudinal direction toward thedistal end 32, thereby advancing theouter sleeve 14 in the distal direction. The transition of theouter sleeve 14 brings a portion of theadapter 16 in contact with theproximal end 30 of thetubular body 12 and advances theneedle 36 through thetubular body 12, as described above, to establish fluid communication between themedical containers - With reference to
FIG. 10 , theouter sleeve 14 may include one or morelongitudinal grooves 52 extending along the inner surface of thesleeve 14. Thelongitudinal grooves 52 are adapted to receive alongitudinal ridge 44, as shown inFIG. 1 , extending along thetubular body 12. Insertion of theridge 44 within thegroove 52 prevents theouter sleeve 14 from rotating relative to thetubular body 12 as thesleeve 14 is pressed downward along thebody 12. Theouter sleeve 14 may include anenlarged extension 54, as shown inFIGS. 8-9 , at the distal end of thesleeve 14. Theextension 54 is adapted to cover thetubular body 12 and thedistal end 32 of theinner sleeve 15 including the portion of theinner sleeve 15 which engages thecontainer 18 orvial adapter 20. - With reference to
FIG. 11 , in a further non-limiting embodiment of the invention, theouter sleeve 14 is configured with a locking mechanism for further securing theouter sleeve 14 in the second position. For example, theouter sleeve 14 may includeinward projections 56 located near the distal end of thesleeve 14. Theprojections 56 may also be positioned on the inner surface of theenlarged extension 54 of thesleeve 14. Theprojections 56 are configured to grasp and maintain contact withcorresponding latches 46 extending radially from thedistal end 32 of thetubular body 12. When theouter sleeve 14 is transitioned to the second position, theprojections 56 engage thelatches 46 of thetubular body 12 forming a secure connection therewith. The engagement between theprojections 56 and latches 46 maintains thesleeve 14 andtubular member 12 in the second position, thereby reducing the chance of inadvertent disconnection. - With reference now to
FIG. 12 , theadapter 16 includes a threadedport 70, acap 72, and ahollow rod 74. Theouter sleeve 14 is connected to theadapter 16 at a proximal portion of thesleeve 14. Theouter sleeve 14 may include aproximal locking structure 58, as shown inFIG. 10 , such as an inwardly projecting rib, latch, or teeth extending from an inner surface of thesleeve 14 to contact and engage theadapter 16. The engagement between theadapter 16 andouter sleeve 14 may prevent rotation of theadapter 16 with respect to thesleeve 14. - With further reference to
FIG. 12 , the threadedport 70 is configured to connect with a nozzle of a syringe thereby establishing the fluid connection between themedical container 18 and thefluid connector 10. The threadedport 70 extends proximally outward from thecap 72. Thecap 72 is generally cylindrical and configured to be inserted in the open proximal end of theouter sleeve 14. Thecap 72 may include aprotrusion 76, which corresponds to theproximal lock 58 of theouter sleeve 14, for retaining the cap within the outer sleeve. The engagement between thecap 72 andouter sleeve 14 may also prevent rotation of theadapter 16 relative to theouter sleeve 14. Therod 74 extends distally from the threadedport 70 toward thetubular body 12. Therod 74 is rigidly attached to theneedle 36 and includes a fluid channel extending through therod 74 for fluid transfer from the threadedport 70 to theneedle 36. As theouter sleeve 14 is transitioned from the first position to the second position, therod 74 is directed distally and is received within thetubular body 12. Continued distal movement of therod 74 advances a portion of theneedle 36 through thetubular body 12, thereby exposing thetip 38 of theneedle 36 through thedistal end 32 of thetubular body 12. In the second position, thecap 72 rests against theproximal end 30 of thetubular body 12, and therod 74 is entirely enclosed within thetubular body 12. - In a preferred and non-limiting embodiment of the invention, the
fluid connector 10, especially theouter sleeve 14, is configured to have a minimized diameter. Thecap 72 is contained almost entirely within theouter sleeve 14 such that only a proximal most portion of thecap 72 and the threadedport 70 extend beyond the end of thesleeve 14. In this configuration, thecap 72 and at least a portion of thesleeve 14 have substantially the same diameter. Anouter sleeve 14 with a reduced diameter can be handled more easily by users. Furthermore, a slimmerouter sleeve 14 is generally more visually pleasing and reduces the apparent complexity of theconnector 10 by limiting the components which are visible to a user. In an alternative embodiment, thecap 72 is configured to cover thesleeve 14 such that a portion of thesleeve 14 is enclosed within an interior cavity formed by thecap 72. - In a further non-limiting embodiment of the invention, the connection between the
adapter 16 andouter sleeve 14 is a selective rotational engagement which can be transitioned from a freely rotatable configuration in which theadapter 16 can be rotated 360 degrees to a locked or non-rotatable position where rotation of theadapter 16 is prevented. Specifically, theprotrusion 76 of thecap 72 forms a ratcheting engagement with theproximal lock 58 of theouter sleeve 14 to allow a syringe ormedical container 18 to be connected to the threadedport 70, but discouraging accidental disconnection. Thus, when tightening themedical container 18 to the threadedport 70, rotation between theadapter 16 and theouter sleeve 14 is prevented. When a user attempts to remove themedical container 18 from the threadedport 70, theadapter 16 will rotate relative to theouter sleeve 14 to discourage disconnection. - With reference to
FIG. 13 , in a further embodiment of the present invention, theconnector 10 is provided with a part having adominant color 80, shown in cross-hatch, and a part having anon-dominant color 82. Users are more likely to grasp and attempt to manipulate portions of a device with thedominant color 80. Therefore, theouter sleeve 14, and specifically the grippingportion 50 of theouter sleeve 14, is provided in thedominant color 80. Dominant colors include red, blue, neon colors, or black, although other suitable dominant colors may be utilized. Thetubular body 12, which is not intended to be grasped by the user, is provided in anon-dominant color 82. Non-dominant colors include pastels, neutral colors such as tan, and white. Since theouter sleeve 14 slides distally along thetubular body 12 it is preferable that the user does not attempt to grasp thetubular body 12. Grasping thebody 12 would prevent the distal movement of theouter sleeve 14. Using a dominant and non-dominant color scheme encourages the user to hold the correct portion of thefluid connector 10. - While the
tubular body 12 is provided mainly with a neutral ornon-dominant color 82, thetubular body 12 may further include avisible detent 84, such as a semispherical projection, extending radially from the outer surface of thetubular body 12. Thevisible detent 84 should be a dominant, highlyvisible color 86. Thevisible detent 84 corresponds to and is adapted to be received within acircular notch 88 in theouter sleeve 14. Thedetent 84 is configured to be received within thenotch 88 when thesleeve 14 is in the second position. When thedetent 84 aligns with thenotch 88, the user is assured that the device has fully transitioned to the second position and that fluid communication through thefluid connector 10 has been established. To further draw a user's attention to thedetent 84 andnotch 88, theouter sleeve 14 may includevisible markings 90 which draw the user's attention to thenotch 88. These markings serve to direct the user's attention to thevisible detent 84 and encourage the user to check whether thedetent 84 and notch 88 are aligned before beginning to inject fluid through thefluid connector 10. Thedetent 84 may also provide a tactile or haptic feedback to indicate when theconnector 10 is in the proper position when in use. - Including features such as the dominant 80 and
non-dominant 82 color scheme andvisible detent 84 increases user confidence when using theconnector 10. The structure and appearance of the device is designed to encourage the user to use the device correctly and to provide visual, tactile, or haptic feedback when a use step has been correctly completed. The visual, tactile, or haptic feedback inspires confidence in a user that subsequent steps will also be correctly completed. - Having described the components of the fluid connector and various exemplary embodiments thereof, a method of using the device will now be described. In use, the
fluid connector 10 is initially provided in the first position, as shown, for example, inFIGS. 1 and2A . The user attaches a syringe to theadapter 16 at the threadedport 70. Specifically, the user places the syringe nozzle about the threadedport 70 and rotates the syringe, thereby engaging the threads of theport 70 with corresponding threads on the inner surface of the syringe nozzle. The user next grasps thefluid connector 10 by the grippingportion 50 located on theouter sleeve 14, and presses the distal end of the device, specifically thedistal end 32 of theinner sleeve 15, to a corresponding connector of afluid container 18 orvial adapter 20. For a male connection, the user pushes the male connector into the corresponding female connector and then rotates the device by grasping thesleeve 14, as shown indicated by line A inFIGS. 1 and2A , to lock thefluid connector 10 in place. - Once the first medical container 18 (i.e., the syringe) and the second medical container or
vial adapter 20 are secured to thefluid connector 10, the device is prepared to be transitioned from the first position to the second position, by distally advancing theouter sleeve 14 relative to thetubular body 12. The user continues to push theouter sleeve 14 in the distal direction until thetubular body 12 is entirely enclosed by theouter sleeve 14 and the outer sleeve cannot advance any further in the distal direction. - Once in the second position, the user is provided with a visual indication that the
connector 10 is in the proper position by thedetent 84 being received within thenotch 88. When thedetent 84 and notch 88 are effectively aligned, the user is assured that the device is in the second position, and that fluid communication between the first and secondmedical containers needle 36 has been established. When fluid communication between the first andsecond containers container 18 to the other 19 or to draw fluid betweencontainers containers second container 19 affixed to the distal end of theconnecter 10 can be removed by moving thesleeve 14 relative to thebody 12 to return theconnector 10 back to the first position and then grasping and rotating thesleeve 14 and lockingstructure 40 to disengage the lockingstructure 40 from thevial adaptor 20. - Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the scope of the appended claims. For example, it is to be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.
Claims (10)
- A fluid connector (10) comprising:an adapter (16) configured to removably attach to a first container, the adapter comprising an access port (70) and a cap (72);an outer sleeve (14) connected to the adapter; anda tubular body (12) retained at least partially within the outer sleeve, the tubular body having a proximal end (30) connected to the adapter and a distal end connected to a second container,wherein the fluid connector (10) is transitionable from a first position in which the first container and the second container are in fluid isolation to a second position in which the first container and the second container are in fluid communication, andwherein at least a portion of the cap (72) of the adapter (16) is retained within the outer sleeve, characterised in that the outer sleeve (14) further comprises an enlarged end portion (54) configured to cover the distal end of the tubular body (12), when the connector (10) is in the second position, wherein in the first position, the tubular body (12) extends beyond a distal end of the outer sleeve (14) and in the second position the outer sleeve (14) covers the distal end of the tubular body (12).
- The fluid connector (10) of claim 1, wherein a portion of the cap retained within the outer sleeve (14) comprises a latching mechanism configured to engage a corresponding latching structure (58) positioned on an inner sidewall of the outer sleeve.
- The fluid connector (10) of claim 1 or 2, wherein the tubular body (12) comprises a needle (36) extending longitudinally through the tubular body from the proximal end to the distal end, the needle defining a lumen.
- The fluid connector (10) of claim 3, wherein in the first position, the needle (36) is entirely enclosed within the fluid connector (10) and in the second position the needle (36) extends beyond a distal end of the fluid connector (10).
- The fluid connector (10) of any one of claims 1-4, wherein the outer sleeve (14) further comprises a latch for establishing a non-removable engagement with the distal end of the tubular body (12).
- The fluid connector (10) of any one of claims 1-5, wherein the outer sleeve (14) comprises a grip portion (50).
- The fluid connector (10) of any one of claims 1-6, wherein the outer sleeve (14) comprises a first dominant color (80) and the tubular body (12) comprises a second color (82), the second color being non-dominant, wherein the first and second colors encourage a user to hold the correct portion of the fluid connector (10) during transition between the first and second position.
- The fluid connector (10) of any one of claims 1-7, wherein the tubular body (12) comprises a detent (84), and wherein the outer sleeve (14) comprises a notch (88) which, when the connector is in the second position, accepts the detent such that the detent is visible to a user after it is accepted within the notch of the outer sleeve (14).
- The fluid connector (10) of claim 8, wherein the outer sleeve (14) is a first dominant color, the detent (84) is a second dominant color, and the tubular body (12) is a non-dominant color, wherein the first and second dominant colors and the non-dominant color of the tubular body encourage a user to hold the correct portion of the fluid connector (10) during transition from the first to the second position, and/or wherein the outer sleeve includes visible lines which direct a user's attention to the notch.
- The fluid connector (10) of claim 1, wherein the cap (72) and at least a portion of the sleeve (14) have substantially the same diameter or a portion of the sleeve (14) is enclosed within an interior cavity formed by the cap (72).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17166713.2A EP3213735B1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261731929P | 2012-11-30 | 2012-11-30 | |
PCT/EP2013/075071 WO2014083149A1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17166713.2A Division EP3213735B1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2925274A1 EP2925274A1 (en) | 2015-10-07 |
EP2925274B1 true EP2925274B1 (en) | 2017-04-26 |
Family
ID=49679527
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17166713.2A Active EP3213735B1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
EP13798332.6A Active EP2925274B1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17166713.2A Active EP3213735B1 (en) | 2012-11-30 | 2013-11-29 | Connector for fluid communication |
Country Status (8)
Country | Link |
---|---|
US (2) | US9724269B2 (en) |
EP (2) | EP3213735B1 (en) |
JP (3) | JP6367820B2 (en) |
CN (1) | CN104902863B (en) |
CA (2) | CA2892488C (en) |
ES (2) | ES2763163T3 (en) |
IL (2) | IL238919B (en) |
WO (1) | WO2014083149A1 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7547300B2 (en) | 2006-04-12 | 2009-06-16 | Icu Medical, Inc. | Vial adaptor for regulating pressure |
WO2010022095A1 (en) | 2008-08-20 | 2010-02-25 | Icu Medical, Inc. | Anti-reflux vial adaptors |
WO2011014525A2 (en) | 2009-07-29 | 2011-02-03 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
CN103501751B (en) * | 2011-03-04 | 2016-11-23 | 杜杰克特医疗系统有限公司 | The transmission system easily coupled |
CA3176437A1 (en) | 2011-08-18 | 2013-02-21 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
KR102481494B1 (en) | 2011-12-22 | 2022-12-26 | 아이씨유 메디칼 인코퍼레이티드 | A medical fluid transfer system, a fluid transfer method, an electronic medical fluid transfer system, and a method of using an electronic medical fluid transfer system |
EP2802377B1 (en) | 2012-01-13 | 2016-12-07 | ICU Medical, Inc. | Pressure-regulating vial adaptors and methods |
AU2013204180B2 (en) | 2012-03-22 | 2016-07-21 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
US9724269B2 (en) | 2012-11-30 | 2017-08-08 | Becton Dickinson and Company Ltd. | Connector for fluid communication |
US9089475B2 (en) | 2013-01-23 | 2015-07-28 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
EP2948125B1 (en) | 2013-01-23 | 2019-05-22 | ICU Medical, Inc. | Pressure-regulating vial adaptors |
US10022301B2 (en) | 2013-03-15 | 2018-07-17 | Becton Dickinson and Company Ltd. | Connection system for medical device components |
CA2918381C (en) | 2013-07-19 | 2023-01-17 | Icu Medical, Inc. | Pressure-regulating fluid transfer systems and methods |
EP3073982B1 (en) | 2013-11-25 | 2020-04-08 | ICU Medical, Inc. | Methods and system for filling iv bags with therapeutic fluid |
RS56845B1 (en) * | 2014-02-07 | 2018-04-30 | Borla Ind | Access device for containers of fluidizable substances |
IL273763B2 (en) | 2014-04-21 | 2023-10-01 | Becton Dickinson & Co Ltd | Fluid transfer device and packaging therefor |
BR112016024683B1 (en) | 2014-04-21 | 2021-12-21 | Becton Dickinson and Company Limited | SYRINGE ADAPTER WITH COMPOUND MOTION DISENGAGEMENT AND METHOD |
EP3733147A1 (en) | 2014-04-21 | 2020-11-04 | Becton Dickinson and Company Limited | Fluid transfer device and packaging therefor |
IL280269B1 (en) * | 2014-04-21 | 2024-08-01 | Becton Dickinson & Co Ltd | Syringe adapter |
EP3157491B1 (en) | 2014-06-20 | 2022-06-22 | ICU Medical, Inc. | Pressure-regulating vial adaptors |
WO2016201232A1 (en) * | 2015-06-12 | 2016-12-15 | Becton Dickinson and Company Limited | Syringe adapter with spinning connector |
EP3383343A4 (en) | 2015-12-04 | 2019-07-10 | ICU Medical, Inc. | Systems methods and components for transferring medical fluids |
PL3397231T3 (en) | 2016-01-29 | 2022-06-27 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
USD851745S1 (en) | 2016-07-19 | 2019-06-18 | Icu Medical, Inc. | Medical fluid transfer system |
WO2018022640A1 (en) | 2016-07-25 | 2018-02-01 | Icu Medical, Inc. | Systems, methods, and components for trapping air bubbles in medical fluid transfer modules and systems |
AU2017335746A1 (en) | 2016-09-30 | 2019-04-11 | Icu Medical, Inc. | Pressure-regulating vial access devices and methods |
IL267972B2 (en) | 2017-01-12 | 2023-10-01 | Becton Dickinson & Co Ltd | Closed system stress resistant membrane |
EP4364784A3 (en) * | 2017-01-17 | 2024-07-24 | Becton Dickinson and Company Limited | Connector for system for closed transfer of fluids |
EP4218895A1 (en) | 2017-01-17 | 2023-08-02 | Becton Dickinson and Company Limited | Syringe adapter with lock mechanism |
US11986441B2 (en) | 2017-01-17 | 2024-05-21 | Becton Dickinson and Company Limited | Syringe adapter for closed transfer of fluids |
BR112019014624A2 (en) | 2017-01-17 | 2020-04-14 | Becton Dickinson & Co Ltd | syringe adapter |
WO2018136357A1 (en) | 2017-01-17 | 2018-07-26 | Becton Dickinson and Company Limited | Syringe adapter with cap |
WO2018224644A1 (en) * | 2017-06-08 | 2018-12-13 | Novartis Ag | Injection device and injection solution transferring system |
JP7212034B2 (en) * | 2017-08-15 | 2023-01-24 | ベクトン・ディキンソン・アンド・カンパニー | Spinning female lure with threaded release configuration |
USD908872S1 (en) | 2018-04-04 | 2021-01-26 | Becton Dickinson and Company Limited | Medical vial access device |
USD888945S1 (en) | 2018-04-04 | 2020-06-30 | Becton Dickinson and Company Limited | Medical connector |
USD873996S1 (en) | 2018-04-04 | 2020-01-28 | Becton Dickinson and Company Limited | Medical syringe adapter |
USD877900S1 (en) | 2018-04-04 | 2020-03-10 | Becton Dickinson and Company Limited | Medical infusion adapter |
CN108420734B (en) * | 2018-04-23 | 2020-11-27 | 曹际海 | Traditional chinese medicine machine of decocting medicinal herbs of recycling |
US11590057B2 (en) | 2020-04-03 | 2023-02-28 | Icu Medical, Inc. | Systems, methods, and components for transferring medical fluids |
CN111558116B (en) * | 2020-05-12 | 2021-08-13 | 吉林大学 | Artificial respiration auxiliary device for doctors in emergency ward of cardiology department |
JP2023546374A (en) | 2020-10-09 | 2023-11-02 | アイシーユー・メディカル・インコーポレーテッド | Fluid transfer device and method of use therefor |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3047178A (en) * | 1958-06-24 | 1962-07-31 | Baxter Laboratories Inc | Closure system |
FR1418064A (en) * | 1964-07-10 | 1965-11-19 | Advanced device for infusion and blood transfusion | |
US3826260A (en) * | 1971-12-27 | 1974-07-30 | Upjohn Co | Vial and syringe combination |
JPS5955372A (en) | 1982-09-25 | 1984-03-30 | 株式会社西村機械製作所 | Tumbler screening machine |
SE434700B (en) * | 1983-05-20 | 1984-08-13 | Bengt Gustavsson | DEVICE FOR AIRED TRANSFER OF SUBSTANCE FROM A KERLE TO ANOTHER |
DE3483475D1 (en) * | 1983-05-20 | 1990-11-29 | Bengt Gustavsson | ARRANGEMENT FOR TRANSFERRING A SUBSTANCE. |
US4898209A (en) * | 1988-09-27 | 1990-02-06 | Baxter International Inc. | Sliding reconstitution device with seal |
DE9105229U1 (en) * | 1991-04-27 | 1991-06-13 | B. Braun Melsungen Ag, 3508 Melsungen | Valve device for a catheter |
JPH06139869A (en) * | 1992-10-28 | 1994-05-20 | Mitsubishi Electric Corp | Push button switch for operation panel |
EP0717611B1 (en) * | 1993-09-07 | 1998-08-12 | Debiotech S.A. | Syringe device for mixing two compounds |
FR2726768A1 (en) * | 1994-11-14 | 1996-05-15 | Debiotech Sa | SYRINGE DEVICE ATTACHABLE TO A VIAL |
US5569209A (en) | 1994-12-21 | 1996-10-29 | Jemm Tran-Safe Systems, Inc. | Needleless transfer system |
IL114960A0 (en) * | 1995-03-20 | 1995-12-08 | Medimop Medical Projects Ltd | Flow control device |
ATE217181T1 (en) * | 1996-01-11 | 2002-05-15 | Duoject Inc | DELIVERY SYSTEM FOR MEDICINAL PRODUCTS PACKED IN PHARMACEUTICAL VIALS |
US6159192A (en) * | 1997-12-04 | 2000-12-12 | Fowles; Thomas A. | Sliding reconstitution device with seal |
JPH11221782A (en) * | 1998-02-09 | 1999-08-17 | Matsushita Electric Works Ltd | Power tool |
US20050137566A1 (en) * | 2003-12-23 | 2005-06-23 | Fowles Thomas A. | Sliding reconstitution device for a diluent container |
US6113583A (en) * | 1998-09-15 | 2000-09-05 | Baxter International Inc. | Vial connecting device for a sliding reconstitution device for a diluent container |
US20020173748A1 (en) * | 1998-10-29 | 2002-11-21 | Mcconnell Susan | Reservoir connector |
FR2790948B1 (en) * | 1999-03-18 | 2001-06-22 | Sedat | DEVICE FOR BIDIRECTIONAL TRANSFER OF A LIQUID BETWEEN A BOTTLE AND A CAPSULE |
US6453956B2 (en) * | 1999-11-05 | 2002-09-24 | Medtronic Minimed, Inc. | Needle safe transfer guard |
US7100646B2 (en) * | 2000-02-11 | 2006-09-05 | Medical Instill Technologies, Inc. | Sealed containers and methods of making and filling same |
SE517084C2 (en) * | 2000-08-10 | 2002-04-09 | Carmel Pharma Ab | Procedures and devices for aseptic preparation |
CN1509192A (en) * | 2001-03-13 | 2004-06-30 | MDCͶ�ʿعɹ�˾ | Pre-filled safety vial injector |
US6715520B2 (en) | 2001-10-11 | 2004-04-06 | Carmel Pharma Ab | Method and assembly for fluid transfer |
US6875205B2 (en) * | 2002-02-08 | 2005-04-05 | Alaris Medical Systems, Inc. | Vial adapter having a needle-free valve for use with vial closures of different sizes |
US7867215B2 (en) * | 2002-04-17 | 2011-01-11 | Carmel Pharma Ab | Method and device for fluid transfer in an infusion system |
US7350535B2 (en) * | 2002-04-26 | 2008-04-01 | Gl Tool And Manufacturing Co. Inc. | Valve |
WO2004041148A1 (en) * | 2002-11-08 | 2004-05-21 | Duoject Medical Systems Inc. | Pharmaceutical delivery systems and methods for using same |
DK2664550T3 (en) * | 2003-10-30 | 2019-11-11 | Simplivia Healthcare Ltd | Device for safe handling of drug |
US7530546B2 (en) * | 2004-01-13 | 2009-05-12 | Rymed Technologies, Inc. | Swabbable needle-free injection port valve system with zero fluid displacement |
IL161660A0 (en) * | 2004-04-29 | 2004-09-27 | Medimop Medical Projects Ltd | Liquid drug delivery device |
JP4710618B2 (en) * | 2005-02-16 | 2011-06-29 | 株式会社ジェイ・エム・エス | Tube clamp device |
GB0510057D0 (en) * | 2005-05-17 | 2005-06-22 | Glaxosmithkline Biolog Sa | Novel device |
US7998134B2 (en) * | 2007-05-16 | 2011-08-16 | Icu Medical, Inc. | Medical connector |
WO2007015233A1 (en) * | 2005-08-01 | 2007-02-08 | Medimop Medical Projects Ltd | Liquid drug delivery system |
JP5132575B2 (en) * | 2005-11-30 | 2013-01-30 | ビヨコール ルシェルシュ エ ディヴェロプマン | Container closure device and container fitted into such device |
US7547300B2 (en) * | 2006-04-12 | 2009-06-16 | Icu Medical, Inc. | Vial adaptor for regulating pressure |
JP5087858B2 (en) | 2006-04-28 | 2012-12-05 | ニプロ株式会社 | Mixed injection connector |
AU2007262025B2 (en) * | 2006-06-19 | 2013-03-14 | Nipro Corporation | Drug Solution Preparation Kit |
US8167863B2 (en) * | 2006-10-16 | 2012-05-01 | Carefusion 303, Inc. | Vented vial adapter with filter for aerosol retention |
US20080262466A1 (en) * | 2007-04-19 | 2008-10-23 | Steve Smith | Storage container |
WO2008129550A2 (en) * | 2007-04-23 | 2008-10-30 | Plastmed Ltd. | Method and apparatus for contamination-free transfer of a hazardous drug |
EP3111911B1 (en) | 2007-05-08 | 2018-10-17 | Carmel Pharma AB | Fluid transfer device |
US7975733B2 (en) | 2007-05-08 | 2011-07-12 | Carmel Pharma Ab | Fluid transfer device |
US20080306439A1 (en) * | 2007-06-08 | 2008-12-11 | Nelson M Bud | Devices for mixing and applying a fluid composition |
WO2009035383A1 (en) | 2007-09-11 | 2009-03-19 | Carmel Pharma Ab | Piercing member protection device |
AU2009203557B2 (en) * | 2008-01-09 | 2014-02-20 | Novartis Ag | Unitary withdrawal spike unit suitable for factory fitting |
FR2928539B1 (en) * | 2008-03-12 | 2012-02-24 | Vygon | INTERFACING DEVICE FOR PERFORATING BOTTLES FOR THE PREPARATION OF PERFUME FLUIDS |
DE102008025011B4 (en) | 2008-05-24 | 2022-12-22 | Tecpharma Licensing Ag | Ampoule with ampoule holder |
WO2010061742A1 (en) | 2008-11-25 | 2010-06-03 | 株式会社ジェイ・エム・エス | Connector |
JP5917152B2 (en) * | 2009-01-30 | 2016-05-11 | バイオコンパティブルス・ユーケー・リミテッド | Method for enhancing leakage resistance of a pressurized closed system with a bulkhead sealed container |
US8864725B2 (en) * | 2009-03-17 | 2014-10-21 | Baxter Corporation Englewood | Hazardous drug handling system, apparatus and method |
JP5333850B2 (en) * | 2009-07-15 | 2013-11-06 | ニプロ株式会社 | Connecting device |
US8277424B2 (en) * | 2009-07-17 | 2012-10-02 | Pan Hsiu-Feng | Needle-less syringe adapter |
JP5363928B2 (en) | 2009-09-09 | 2013-12-11 | 株式会社トップ | Medical connector |
IL202070A0 (en) * | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
EP2501355B1 (en) * | 2009-11-20 | 2014-09-24 | Carmel Pharma AB | Medical device connector |
US9205248B2 (en) * | 2010-02-24 | 2015-12-08 | Becton, Dickinson And Company | Safety Drug delivery connectors |
WO2012002314A1 (en) * | 2010-06-30 | 2012-01-05 | テルモ株式会社 | Connector and connector assembly |
CN102614557A (en) | 2011-01-30 | 2012-08-01 | 姜方仑 | Medicating connector with hidden needle tubing |
EP2765972B1 (en) * | 2011-10-14 | 2016-01-13 | Novo Nordisk Health Care AG | Pre-assembled fluid transfer arrangement |
EP2787951B1 (en) * | 2011-12-08 | 2016-03-16 | Novo Nordisk Health Care AG | Medical device having integrated sequence control |
CN202408919U (en) | 2012-01-19 | 2012-09-05 | 青岛大学医学院附属医院 | Disposable anti-puncture empty needle |
WO2013150576A1 (en) * | 2012-04-02 | 2013-10-10 | 株式会社メディカルクリエーション | Drug delivery device |
US9724269B2 (en) * | 2012-11-30 | 2017-08-08 | Becton Dickinson and Company Ltd. | Connector for fluid communication |
US10022301B2 (en) * | 2013-03-15 | 2018-07-17 | Becton Dickinson and Company Ltd. | Connection system for medical device components |
CA2924534C (en) * | 2013-09-23 | 2018-08-14 | Becton Dickinson and Company Ltd. | Piercing member for container access device |
WO2015069654A1 (en) * | 2013-11-06 | 2015-05-14 | Becton Dickinson and Company Limited | System for closed transfer of fluids having connector |
BR112016024683B1 (en) * | 2014-04-21 | 2021-12-21 | Becton Dickinson and Company Limited | SYRINGE ADAPTER WITH COMPOUND MOTION DISENGAGEMENT AND METHOD |
-
2013
- 2013-11-27 US US14/091,603 patent/US9724269B2/en active Active
- 2013-11-29 CA CA2892488A patent/CA2892488C/en active Active
- 2013-11-29 JP JP2015544475A patent/JP6367820B2/en active Active
- 2013-11-29 CA CA2971919A patent/CA2971919C/en active Active
- 2013-11-29 CN CN201380068941.2A patent/CN104902863B/en active Active
- 2013-11-29 EP EP17166713.2A patent/EP3213735B1/en active Active
- 2013-11-29 WO PCT/EP2013/075071 patent/WO2014083149A1/en active Application Filing
- 2013-11-29 ES ES17166713T patent/ES2763163T3/en active Active
- 2013-11-29 ES ES13798332.6T patent/ES2633180T3/en active Active
- 2013-11-29 EP EP13798332.6A patent/EP2925274B1/en active Active
-
2015
- 2015-05-20 IL IL238919A patent/IL238919B/en active IP Right Grant
-
2017
- 2017-06-30 US US15/639,123 patent/US10813838B2/en active Active
-
2018
- 2018-07-05 JP JP2018128421A patent/JP6698754B2/en active Active
-
2020
- 2020-04-23 IL IL274171A patent/IL274171B2/en unknown
- 2020-04-28 JP JP2020079293A patent/JP7071431B2/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
CA2971919C (en) | 2021-03-02 |
CA2892488C (en) | 2017-08-15 |
IL274171B1 (en) | 2023-04-01 |
CN104902863B (en) | 2017-10-13 |
JP2018149423A (en) | 2018-09-27 |
IL274171A (en) | 2020-06-30 |
EP3213735A1 (en) | 2017-09-06 |
US10813838B2 (en) | 2020-10-27 |
JP2020110729A (en) | 2020-07-27 |
CA2892488A1 (en) | 2014-06-05 |
US20140150925A1 (en) | 2014-06-05 |
ES2763163T3 (en) | 2020-05-27 |
JP7071431B2 (en) | 2022-05-18 |
CA2971919A1 (en) | 2014-06-05 |
US9724269B2 (en) | 2017-08-08 |
US20170296433A1 (en) | 2017-10-19 |
ES2633180T3 (en) | 2017-09-19 |
EP2925274A1 (en) | 2015-10-07 |
JP2015535472A (en) | 2015-12-14 |
IL238919A0 (en) | 2015-07-30 |
IL238919B (en) | 2021-03-25 |
IL274171B2 (en) | 2023-08-01 |
JP6367820B2 (en) | 2018-08-01 |
EP3213735B1 (en) | 2019-10-16 |
WO2014083149A1 (en) | 2014-06-05 |
JP6698754B2 (en) | 2020-05-27 |
CN104902863A (en) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10813838B2 (en) | Connector for fluid communication | |
US10517797B2 (en) | Syringe adapter with compound motion disengagement | |
EP2822617B1 (en) | Drug reconstitution system | |
TW201501707A (en) | Vial adapter | |
CN102548523A (en) | Vial assemblage with vial and pre-attached fluid transfer device | |
EP3067037B1 (en) | A safety medical transfer device | |
CA3070228C (en) | Spinning female luer with threadably removable feature |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150623 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20160408 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20161118 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BECTON DICKINSON AND COMPANY LTD. |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 887245 Country of ref document: AT Kind code of ref document: T Effective date: 20170515 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013020385 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170426 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 887245 Country of ref document: AT Kind code of ref document: T Effective date: 20170426 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2633180 Country of ref document: ES Kind code of ref document: T3 Effective date: 20170919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170726 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170727 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170726 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170826 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013020385 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20180129 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171129 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20171130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171129 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20131129 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170426 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231019 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20231201 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20231020 Year of fee payment: 11 Ref country code: IT Payment date: 20231019 Year of fee payment: 11 Ref country code: IE Payment date: 20231023 Year of fee payment: 11 Ref country code: FR Payment date: 20231020 Year of fee payment: 11 Ref country code: DE Payment date: 20231019 Year of fee payment: 11 |